The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · cited 3×
“In addition, ntibody-dependent tumor recognition via Fc receptors is a lausible mechanism of action of neutrophils leading to death f tumor cells, by ‘antibody-dependent cellular cytotoxicity’ ADCC) [57,58].”
BackgroundVEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Neutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
ECM and Cell Surface Proteolysis: Regulating Cellular Ecology
Werb, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80429-8 · Cited by 1,307
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
Self-citationNozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
The neutrophil as a cellular source of chemokines
Scapini, P., Lapinet‐Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., & Cassatella, M. A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17706.x · Cited by 802
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2084 · Cited by 744
Neutrophil granules: a library of innate immunity proteins
Borregaard, N., Sørensen, O. E., & Theilgaard-Mönch, K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.06.002 · Cited by 739
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Gelatinase B functions as regulator and effector in leukocyte biology
Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., & Van Damme, J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.851 · Cited by 553
Self-citationLoss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
DNA Damage-Mediated Induction of a Chemoresistant Niche
Gilbert, L. A., & Hemann, M. T. (2010) · Cell · doi:10.1016/j.cell.2010.09.043 · Cited by 428
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., & Musiani, P. (2001) · Blood · doi:10.1182/blood.v97.2.339 · Cited by 419
Gelatinase B: a tuner and amplifier of immune functions
Opdenakker, G., Van den Steen, P. E., & Van Damme, J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02023-3 · Cited by 402
Self-citationHuh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352
Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow
Breitbach, C. J., Paterson, J. M., Lemay, C. G., Falls, T. J., McGuire, A., Parato, K. A., Stojdl, D. F., Daneshmand, M., Speth, K., Kirn, D., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300215 · Cited by 277
K-ras activation generates an inflammatory response in lung tumors
Ji, H., Houghton, A. M., Mariani, T. J., Perera, S., Kim, C. B., Padera, R., Tonon, G., McNamara, K., Marconcini, L. A., Hezel, A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209237 · Cited by 271
MASURE, S., PROOST, P., VAN DAMME, J., & OPDENAKKER, G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16027.x · Cited by 254
Self-citationSun, Z., & Yang, P. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01414-7 · Cited by 244
Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J., Mayaud, C. M., Milleron, B. J., Baud, L., & Cadranel, J. L. (1998) · PubMed Central · Cited by 228
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Kousis, P. C., Henderson, B. W., Maier, P. G., & Gollnick, S. O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1778 · Cited by 224
Tumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212
Gutiérrez-Fernández, A., Fueyo, A., Folgueras, A. R., Garabaya, C., Pennington, C. J., Pilgrim, S., Edwards, D. R., Holliday, D. L., Jones, J. L., Span, P. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5154 · Cited by 207
Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 200
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
Masson, V., De La Ballina, L. R., Munaut, C., Wielockx, B., Jost, M., Maillard, C., Blacher, S., Bajou, K., Itoh, T., Itohara, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2140fje · Cited by 183
Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., di Pierro, F., & De Giovanni, C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3112 · Cited by 180
Cavallo, F., Giovarelli, M., Gulino, A., Vacca, A., Stoppacciaro, A., Modesti, A., & Forni, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3627 · Cited by 180
Loukinova, E., Dong, G., Enamorado-Ayalya, I., Thomas, G. R., Chen, Z., Schreiber, H., & Van Waes, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203687 · Cited by 172
Refractoriness to Antivascular Endothelial Growth Factor Treatment: Role of Myeloid Cells
Shojaei, F., & Ferrara, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0925 · Cited by 171
Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8
Schaider, H., Oka, M., Bogenrieder, T., Nesbit, M., Satyamoorthy, K., Berking, C., Matsushima, K., & Herlyn, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10775 · Cited by 169
Redondo-Muñóz, J., Ugarte-Berzal, E., Terol, M. J., den Steen, P. E. V., del Cerro, M. H., Roderfeld, M., Roeb, E., Opdenakker, G., Garcia-Marco, J. A., & Garcı́a-Pardo, A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.044 · Cited by 167
Self-citationThe paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Tong, Z., Kunnumakkara, A. B., Wang, H., Matsuo, Y., Diagaradjane, P., Harikumar, K. B., Ramachandran, V., Sung, B., Chakraborty, A., Bresalier, R. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0540 · Cited by 165
Piccard, H., Van den Steen, P. E., & Opdenakker, G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006629 · Cited by 162
Self-citationWelch, D. R., Schissel, D. J., Howrey, R. P., & Aeed, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5859 · Cited by 161
Ardi, V. C., den Steen, P. E. V., Opdenakker, G., Schweighofer, B., Deryugina, E. I., & Quigley, J. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033472 · Cited by 161
Self-citationCytokines, tumour-cell death and immunogenicity: a question of choice
Musiani, P., Modesti, A., Giovarelli, M., Cavallo, F., Forni, G., Lollini, P. L., & Colombo, M. P. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80012-6 · Cited by 159
Gijsbers, K., Gouwy, M., Struyf, S., Wuyts, A., Proost, P., Opdenakker, G., Penninckx, F., Ectors, N., Geboes, K., & Van Damme, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.027 · Cited by 158
Self-citationOpdenakker, G., & Damme, J. V. (1992) · Cytokine · doi:10.1016/1043-4666(92)90064-x · Cited by 158
Self-citationThe discovery of the placental growth factor and its role in angiogenesis: a historical review
Ribatti, D. (2008) · Angiogenesis · doi:10.1007/s10456-008-9114-4 · Cited by 158
The molecular basis of leukocytosis
Opdenakker, G., Fibbe, W. E., & Damme, J. V. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01243-7 · Cited by 154
Self-citationTumor Microenvironment and Angiogenesis
Davis, D. W., Herbst, R. S., & Abbruzzese, J. L. (2007) · CRC Press eBooks · doi:10.1201/9781420004298-10 · Cited by 145
Close encounters of neutrophils and DCs
van Gisbergen, K. P. J. M., Geijtenbeek, T. B. H., & van Kooyk, Y. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.007 · Cited by 136
IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration
Lee, L., Hellendall, R. P., Wang, Y., Haskill, J. S., Mukaida, N., Matsushima, K., & Ting, J. P. ‐. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2769 · Cited by 132
Neutrophil elastase and cancer
Sato, T., Takahashi, S., Mizumoto, T., Harao, M., Akizuki, M., Takasugi, M., Fukutomi, T., & Yamashita, J. (2006) · Surgical Oncology · doi:10.1016/j.suronc.2007.01.003 · Cited by 131
Hirose, K., Hakozaki, M., Nyunoya, Y., Kobayashi, Y., Matsushita, K., Takenouchi, T., Mikata, A., Mukaida, N., & Matsushima, K. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.398 · Cited by 105
Neutrophils influence melanoma adhesion and migration under flow conditions
Slattery, M. J., & Dong, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11297 · Cited by 103
Kushner, B. H., & Cheung, N. (1992) · Blood · doi:10.1182/blood.v79.6.1484.1484 · Cited by 101
Souto, J. C., Vila, L., & Brú, A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20185 · Cited by 101
Musiani, P., Allione, A., Modica, A., Lollini, P., Giovarelli, M., Cavallo, F., Belardelli, F., Forni, G., & Modesti, A. (1996) · PubMed · Cited by 101
Chemotactic factors, passive invasion and metastasis of cancer cells
Opdenakker, G., & Damme, J. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90079-m · Cited by 92
Self-citationActivation of neutrophils by interleukins-1 and -2 and tumor necrosis factors.
Ferrante, A. (1992) · PubMed · Cited by 91
Neutrophils in the Antitumoral Immune Response
Carlo, E. D., Forni, G., & Musiani, P. (2003) · KARGER eBooks · doi:10.1159/000071561 · Cited by 91
Colombo, M. P., Lombardi, L., Stoppacciaro, A., Melani, C. C., Parenza, M., Bottazzi, B., & Parmiani, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.113 · Cited by 88
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Elsässer, D., Valerius, T., Repp, R., Weiner, G. J., Deo, Y. M., Kalden, J., van de Winkel, J. G. J., Stevenson, G., Glennie, M. J., & Gramatzki, M. (1996) · Blood · doi:10.1182/blood.v87.9.3803.bloodjournal8793803 · Cited by 86
Human Neutrophil-Mediated Cytotoxicity to Tumor Cells 2 3
Gerrard, T. L., Cohen, D., & Kaplan, A. M. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/66.3.483 · Cited by 84
Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent Principle
Coillie, E. V., Aelst, I. V., Wuyts, A., Vercauteren, R., Devos, R., Wolf‐Peeters, C. D., Damme, J. V., & Opdenakker, G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62527-8 · Cited by 83
Self-citationAlvarez, M. J., Prada, F., Salvatierra, E., Bravo, A., Lutzky, V. P., Carbone, C., Pitossi, F. J., Chuluyán, E., & Podhajcer, O. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1102 · Cited by 83
Opdenakker, G., & Damme, J. V. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041796go · Cited by 77
Self-citationDong, C., Slattery, M. J., Liang, S., & Peng, H. (2005) · PubMed · Cited by 76
Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response
Peng, H., Liang, S., Henderson, A. J., & Dong, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.030 · Cited by 74
Dallegri, F., Ottonello, L. C., Ballestrero, A., Dapino, P., Ferrando, F., Patrone, F., & Sacchetti, C. A. S. (1991) · Inflammation · doi:10.1007/bf00917906 · Cited by 73
Neutrophils but Not Eosinophils Are Involved in Growth Suppression of IL-4-Secreting Tumors
Noffz, G., Qin, Z., Köpf, M., & Blankenstein, T. J. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.345 · Cited by 72
Liang, S., Slattery, M. J., & Dong, C. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.028 · Cited by 71
Fas Ligand on Tumor Cells Mediates Inactivation of Neutrophils
Chen, Y.-L., Chen, S., Wang, J., & Yang, B.-C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1183 · Cited by 70
Development of targeted angiogenic medicine
Loges, S., Roncal, C., & Carmeliet, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03203.x · Cited by 67
Zhang, P., Özdemir, T., Chung, C.-Y., Robertson, G. P., & Dong, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000494 · Cited by 53
Myeloid cell diversification and complexity: an old concept with new turns in oncology
Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., & Bronte, V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9268-1 · Cited by 47
Oxidative burst and anticancer activities of rat neutrophils
Živković, M., Poljak‐Blaži, M., Egger, G., Šunjić, S. B., Schaur, R. J., & Žarković, N. (2005) · BioFactors · doi:10.1002/biof.5520240136 · Cited by 41
Early Membrane Rupture Events During Neutrophil-Mediated Antibody-Dependent Tumor Cell Cytolysis
Kindzelskii, A. L., & Petty, H. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3188 · Cited by 35
Yui, S., Tomita, K., Kudo, T., Ando, S., & Yamazaki, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00097.x · Cited by 34
Sanford, M. A., Yan, Y., Canfield, S. E., Hassan, W. N., Selleck, W. A., Atkinson, G., Chen, S., & Hall, S. J. (2001) · Human Gene Therapy · doi:10.1089/10430340152480221 · Cited by 31
van den Tol, M. P., Raa, S. T., van Grevenstein, W. M. U., van Rossen, M. E. E., Jeekel, J. J., & van Eijck, C. H. J. (2007) · Digestive Surgery · doi:10.1159/000107781 · Cited by 28
The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy
Molema, G., Kroesen, B. J., Helfrich, W., Meijer, D. K. F., & de Leij, L. F. M. H. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00137-6 · Cited by 25
Elsässer, D., Stadick, H., Stark, S. E., van de Winkel, J. G. J., Gramatzki, M., Schrott, K. M., Valerius, T., & Schafhauser, W. (1999) · PubMed · Cited by 24
Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bödey, B., Bödey, B., Siegel, S. E., et al. (1997) · PubMed · Cited by 23
Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer
Yao, C., Lin, Y., Ye, C., Bi, J., Zhu, Y., & Wang, S. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200710020-00007 · Cited by 22
In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β
Neville, M. E., Pezzella, K. M., Schmidt, K., Galbraith, W., & Ackerman, N. R. (1990) · Cytokine · doi:10.1016/1043-4666(90)90055-x · Cited by 21
Schrötzlmair, F., Kopitz, C., Halbgewachs, B., Lu, F., Algül, H., Brünner, N., Gänsbacher, B., & Krüger, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00951.x · Cited by 20
Colombo, M. P., Lombardi, L., Melani, C. C., et al. (1996) · PubMed · Cited by 19
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
The multifaceted functions of neutrophils
Mayadas, T. N., Cullere, X., & Lowell, C. A. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164023 · Cited by 1,356
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Metadata
- Authors
- Piccard, H., Muschel, R. J., & Opdenakker, G.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 82
- Issue
- 3
- Pages
- 296-309
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2157096396
- Cited by
- 373
- References
- 103
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.